These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 12100758)
1. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells. Li HL; Zhang HW; Chen DD; Zhong L; Ren XD; St-Tu R Acta Pharmacol Sin; 2002 Jul; 23(7):631-7. PubMed ID: 12100758 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Uefuji K; Ichikura T; Shinomiya N; Mochizuki H Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258 [TBL] [Abstract][Full Text] [Related]
3. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells. Nagahara T; Okano J; Murawaki Y Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586 [TBL] [Abstract][Full Text] [Related]
5. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study]. Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595 [TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS; Liu DS; Dai CW; Li RJ Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664 [TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 (COX-2) in human esophageal cancer and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Yu HP; Shi LY; Lu WH; Su YH; Li YY; Xu SQ J Gastroenterol Hepatol; 2004 Jun; 19(6):638-42. PubMed ID: 15151617 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of the sensitivity of renal cell carcinoma cells to fas-mediated cytotoxicity and apoptosis by the selective cyclooxygenase-2 inhibitor JTE-522. Sato N; Mizutani Y; Li YN; Fujiwara J; Ishida H; Toiyama D; Abe K; Hayashi I; Nakanishi H; Kawauchi A; Miki T Urol Int; 2010; 84(3):362-8. PubMed ID: 20389170 [TBL] [Abstract][Full Text] [Related]
11. A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line. Yamashita H; Osaki M; Honjo S; Yoshida H; Teshima R; Ito H Anticancer Res; 2003; 23(6C):4671-6. PubMed ID: 14981912 [TBL] [Abstract][Full Text] [Related]
12. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126. Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831 [TBL] [Abstract][Full Text] [Related]
13. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. Liu X; Yue P; Zhou Z; Khuri FR; Sun SY J Natl Cancer Inst; 2004 Dec; 96(23):1769-80. PubMed ID: 15572759 [TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor. Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736 [TBL] [Abstract][Full Text] [Related]
15. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. Konturek PC; Kania J; Kukharsky V; Ocker S; Hahn EG; Konturek SJ J Physiol Pharmacol; 2003 Mar; 54(1):17-32. PubMed ID: 12674216 [TBL] [Abstract][Full Text] [Related]
16. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor. Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187 [TBL] [Abstract][Full Text] [Related]
17. A selective cyclooxygenase-2 inhibitor, NS398, inhibits cell growth and induces cell cycle arrest in the G2/M phase in human esophageal squamous cell carcinoma cells. Kase S; Osaki M; Honjo S; Takeda A; Adachi K; Araki K; Ito H J Exp Clin Cancer Res; 2004 Jun; 23(2):301-7. PubMed ID: 15354416 [TBL] [Abstract][Full Text] [Related]
18. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer. Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003 [TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone. Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human colon cancer cells. Tang X; Sun YJ; Half E; Kuo MT; Sinicrope F Cancer Res; 2002 Sep; 62(17):4903-8. PubMed ID: 12208739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]